share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

輝瑞 | 4：持股變動聲明-高管 Denton David M
美股SEC公告 ·  09/17 01:06

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 09/12/2024, does not include details on the number of shares traded, the nature of the shares, the transaction price, or the total value of the shares. The report also does not specify the number of shares held by Denton after the action. The absence of this information limits the ability to assess the full impact of the transaction on Pfizer's stock.
Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 09/12/2024, does not include details on the number of shares traded, the nature of the shares, the transaction price, or the total value of the shares. The report also does not specify the number of shares held by Denton after the action. The absence of this information limits the ability to assess the full impact of the transaction on Pfizer's stock.
輝瑞公司（PFE）報告了一筆涉及首席財務官兼執行副總裁Denton David M.的交易。交易日期爲2024年9月12日，但未提供有關交易的股票數量、股票性質、交易價格或股票總價值的詳細信息。該報告還未說明Denton在此次交易後的持股數量。缺乏這些信息會限制評估該交易對輝瑞股票的完全影響能力。
輝瑞公司（PFE）報告了一筆涉及首席財務官兼執行副總裁Denton David M.的交易。交易日期爲2024年9月12日，但未提供有關交易的股票數量、股票性質、交易價格或股票總價值的詳細信息。該報告還未說明Denton在此次交易後的持股數量。缺乏這些信息會限制評估該交易對輝瑞股票的完全影響能力。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間